These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26917410)

  • 1. Targeting peptidyl-prolyl isomerase pin1 to inhibit tumor cell aggressiveness.
    Beretta GL; De Cesare M; Albano L; Magnifico A; Carenini N; Corna E; Perego P; Gatti L
    Tumori; 2016; 102(2):144-9. PubMed ID: 26917410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer.
    Ryo A; Uemura H; Ishiguro H; Saitoh T; Yamaguchi A; Perrem K; Kubota Y; Lu KP; Aoki I
    Clin Cancer Res; 2005 Oct; 11(20):7523-31. PubMed ID: 16243827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decursin exerts anti-cancer activity in MDA-MB-231 breast cancer cells via inhibition of the Pin1 activity and enhancement of the Pin1/p53 association.
    Kim JH; Jung JH; Kim SH; Jeong SJ
    Phytother Res; 2014 Feb; 28(2):238-44. PubMed ID: 23580332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
    Ryo A; Liou YC; Lu KP; Wulf G
    J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolyl-isomerase Pin1 impairs trastuzumab sensitivity by up-regulating fatty acid synthase expression.
    Yun HJ; Kim JY; Kim G; Choi HS
    Anticancer Res; 2014 Mar; 34(3):1409-16. PubMed ID: 24596388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.
    Lam PB; Burga LN; Wu BP; Hofstatter EW; Lu KP; Wulf GM
    Mol Cancer; 2008 Dec; 7():91. PubMed ID: 19077306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rotamase Pin1 is up-regulated, hypophosphorylated and required for cell cycle progression in head and neck squamous cell carcinomas.
    Wiegand S; Dakic B; Rath AF; Makarova G; Sterz C; Meissner W; Bette M; Adamkiewicz J; Müller-Brüsselbach S; Müller R; Werner JA; Mandic R
    Oral Oncol; 2009 Oct; 45(10):e140-9. PubMed ID: 19502098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The peptidyl-prolyl isomerase Pin1.
    Joseph JD; Yeh ES; Swenson KI; Means AR; Winkler
    Prog Cell Cycle Res; 2003; 5():477-87. PubMed ID: 14593743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer.
    Khanal P; Kim G; Lim SC; Yun HJ; Lee KY; Choi HK; Choi HS
    FASEB J; 2013 Nov; 27(11):4606-18. PubMed ID: 23934277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response.
    Zheng H; You H; Zhou XZ; Murray SA; Uchida T; Wulf G; Gu L; Tang X; Lu KP; Xiao ZX
    Nature; 2002 Oct; 419(6909):849-53. PubMed ID: 12397361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells.
    Lee KY; Lee JW; Nam HJ; Shim JH; Song Y; Kang KW
    Mol Cells; 2011 Jul; 32(1):107-11. PubMed ID: 21573702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults.
    Zacchi P; Gostissa M; Uchida T; Salvagno C; Avolio F; Volinia S; Ronai Z; Blandino G; Schneider C; Del Sal G
    Nature; 2002 Oct; 419(6909):853-7. PubMed ID: 12397362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-150-5p inhibits the proliferation and invasion of human larynx epidermiod cancer cells though regulating peptidyl-prolyl cis/trans isomerase.
    Chen H; Cai X; Du B; Cai J; Luo Z
    Braz J Otorhinolaryngol; 2023; 89(3):383-392. PubMed ID: 37105032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
    Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
    Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma.
    Teng BL; Hacker KE; Chen S; Means AR; Rathmell WK
    Mol Oncol; 2011 Oct; 5(5):465-74. PubMed ID: 21764651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidyl Prolyl Isomerase PIN1 Directly Binds to and Stabilizes Hypoxia-Inducible Factor-1α.
    Han HJ; Kwon N; Choi MA; Jung KO; Piao JY; Ngo HK; Kim SJ; Kim DH; Chung JK; Cha YN; Youn H; Choi BY; Min SH; Surh YJ
    PLoS One; 2016; 11(1):e0147038. PubMed ID: 26784107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1.
    Khanal P; Namgoong GM; Kang BS; Woo ER; Choi HS
    Mol Cancer Ther; 2010 Mar; 9(3):606-16. PubMed ID: 20179161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction.
    Chen SY; Wulf G; Zhou XZ; Rubin MA; Lu KP; Balk SP
    Mol Cell Biol; 2006 Feb; 26(3):929-39. PubMed ID: 16428447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIN1 expression contributes to hepatic carcinogenesis.
    Pang RW; Lee TK; Man K; Poon RT; Fan ST; Kwong YL; Tse E
    J Pathol; 2006 Sep; 210(1):19-25. PubMed ID: 16841372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines.
    Kanaoka R; Kushiyama A; Seno Y; Nakatsu Y; Matsunaga Y; Fukushima T; Tsuchiya Y; Sakoda H; Fujishiro M; Yamamotoya T; Kamata H; Matsubara A; Asano T
    PLoS One; 2015; 10(6):e0127467. PubMed ID: 26039047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.